TriStar Health Partners

  • Home
  • About
    • TriStar
    • Team
  • News
  • Investment Strategy
    • Investment Strategy
    • Economic Development Fund – TN Investco
  • Portfolio
  • Contact

Exciting Clinical Results Presented On Endovascular Hemodialysis Access Technology

January 27, 2017 By tstventures2015

TVA Medical, Inc. today announced several clinical updates involving its everlinQ™ endoAVF System, an innovative endovascular technique to create hemodialysis access without open surgery, with other potential clinical applications. The everlinQ endoAVF System has European CE Mark and Health Canada Medical Device License for end-stage renal disease (ESRD) patients who need hemodialysis, and commercialization has begun at select centers in Europe. It is not commercially available in the United States and is currently under review by the U.S. Food and Drug Administration. (read more)

Filed Under: News

Our Portfolio


VIEW MORE

Subscribe to News & Events

Contact Us

Thank you for your interest in TriStar Health Partners. If you have questions or need further information, please contact us!

TriStar Health Partners

3322 West End Ave, Suite 1100 | Nashville, TN 37203
615.515-9880

Copyright © 2023 TriStar Technology Ventures. All rights reserved (CC-licensed photos excepted).